1,250 Manufacturing Sites Inspected Under Risk Based Framework
Mumbai, February 23: The Central Drugs Standard Control Organisation has completed audits of more than 90 per cent of cough syrup manufacturers across the country, as part of an intensified quality compliance drive. A senior official...
audit
capa (corrective and preventive action)
central drugs standard control organisation
coughsyrup
drugs controller general of india
good manufacturing practices
india
mumbai
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical quality
quality control
regulatory compliance
risk-based inspection
